SYGNIS AG reported earnings results for the nine months ended September 30, 2015. For the period, the company reported in the first nine months of the year revenues amounted to EUR 307,000 against EUR 302,000 a year ago. Higher sales of proprietary kits were able to balance lower revenues from the Caco-2 business which were exceptionally higher in the nine-months-period of the previous year. In the third quarter kit sales experienced an increasing demand and repeat orders by several distributors and customers. Due to special one-off factors as a result of additional reorganization and optimization measures, the expansion of kit production and direct selling activities operating expenses were up to EUR 3,026,000 (EUR 2,656,000). Cash outflow from operating activities amounted to EUR 3,120,000 against EUR 2,561,000 a year ago. LBIT (before special factors) was EUR 2,350,000 against EUR 2,269,000 a year ago. LBIT was EUR 2,713,000 against EUR 2,269,000 a year ago. Net loss for the period was EUR 2,779,000 against EUR 2,365,000 a year ago.

In the remaining quarter of the current fiscal year, The company expects revenues from its own products lines TruePrime and SunScript and from the license agreement with Qiagen for additional products based on SensiPhi. Depending on the success of these commercialization activities, the Management Board maintains its initial guidance for 2015, forecasting revenues for the whole year between EUR 500,000 and EUR 700,000.